Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
New York, Sept. 24, 2021 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Psoriatic Arthritis Treatment Global Market Report 2021: COVID-19 Growth And Change To 2030" -...
-
Beverly Hills , July 29, 2021 (GLOBE NEWSWIRE) -- Higher education specialist Bakhtiyor Isoev released two new episodes of the Education & Empowerment Podcast. The episodes feature interviews...
-
Thousand Oaks, CA, June 28, 2021 (GLOBE NEWSWIRE) -- CBDual Biotechnology Corp's parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer of a unique line of premium CBD based oral health...
-
- Collaboration leverages expertise and capabilities of both companies towards developing life-changing treatments for severe neurological diseases - ZUG, Switzerland and CAMBRIDGE, Mass. and...
-
THOUSAND OAKS, CA, May 04, 2021 (GLOBE NEWSWIRE) -- CBDual Biotechnology Corp's parent company, THC Farmaceuticals, Inc (OTC: CBDG), developer of a unique line of premium CBD based oral health...
-
Los Angeles, CA, April 14, 2021 (GLOBE NEWSWIRE) -- As part of its ongoing expansion, Younan Properties has just acquired 60 & 100 Rancho Road, a rare boutique of executive office buildings...
-
Pune, India, Feb. 22, 2021 (GLOBE NEWSWIRE) -- The North America osteoporosis treatment market size is expected to gain momentum by reaching USD 8.29 billion by 2027 while exhibiting a CAGR of 6.6%...
-
16 févr. 2021 16h30 HE | Source: Apollo Global Management, Inc.; Athene Holding Ltd., AmeriHome Mortgage Company, LLC
NEW YORK, HAMILTON, Bermuda, and THOUSAND OAKS, Calif., Feb. 16, 2021 (GLOBE NEWSWIRE) -- Apollo Global Management, Inc. (NYSE: APO) (together with its consolidated subsidiaries, “Apollo”), Athene...
-
Pune, India, Feb. 12, 2021 (GLOBE NEWSWIRE) -- The global leukemia therapeutics market size is projected to reach USD 27.78 billion by 2027, exhibiting a CAGR of 8.1% during the forecast period. The...
-
THOUSAND OAKS, Calif., Feb. 01, 2021 (GLOBE NEWSWIRE) -- Dyve Biosciences, Inc. (“Dyve”), a clinical stage biotechnology company, today announced that Camilla V. Simpson has joined Dyve’s Board of...